BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med. 2008;49 Suppl 2:113S-128S. [PMID: 18523069 DOI: 10.2967/jnumed.107.045922] [Cited by in Crossref: 371] [Cited by in F6Publishing: 351] [Article Influence: 26.5] [Reference Citation Analysis]
Number Citing Articles
1 Hinge N, Pandey MM, Singhvi G, Gupta G, Mehta M, Satija S, Gulati M, Dureja H, Dua K. Nanomedicine advances in cancer therapy. Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering. Elsevier; 2020. pp. 219-53. [DOI: 10.1016/b978-0-12-818471-4.00008-x] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Li G, Chi CW, Shao XF, Fang CH. Application of molecular imaging technology in evaluating the inhibiting effect of apigenin in vivo on subcutaneous hepatocellular carcinoma. Biochem Biophys Res Commun 2017;487:122-7. [PMID: 28408212 DOI: 10.1016/j.bbrc.2017.04.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
3 Kim MH, Kim SG, Kim DW. A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery. Ann Nucl Med 2019;33:606-16. [PMID: 31134434 DOI: 10.1007/s12149-019-01369-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Shi J, Hong H, Ding Y, Yang Y, Cai W, Wang X. Evolution of Zinc Oxide Nanostructures through Kinetics Control. J Mater Chem 2011;21:9000-8. [PMID: 21743779 DOI: 10.1039/C1JM10918A] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
5 He X, Gao J, Gambhir SS, Cheng Z. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med 2010;16:574-83. [PMID: 20870460 DOI: 10.1016/j.molmed.2010.08.006] [Cited by in Crossref: 161] [Cited by in F6Publishing: 152] [Article Influence: 13.4] [Reference Citation Analysis]
6 Desar IM, van Herpen CM, van Laarhoven HW, Barentsz JO, Oyen WJ, van der Graaf WT. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Cancer Treat Rev. 2009;35:309-321. [PMID: 19136215 DOI: 10.1016/j.ctrv.2008.12.001] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 9.6] [Reference Citation Analysis]
7 Edelman RR. The history of MR imaging as seen through the pages of radiology. Radiology 2014;273:S181-200. [PMID: 25340436 DOI: 10.1148/radiol.14140706] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
8 Guo J, Lang L, Hu S, Guo N, Zhu L, Sun Z, Ma Y, Kiesewetter DO, Niu G, Xie Q, Chen X. Comparison of three dimeric 18F-AlF-NOTA-RGD tracers. Mol Imaging Biol 2014;16:274-83. [PMID: 23982795 DOI: 10.1007/s11307-013-0668-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
9 Wang G, Inturi S, Serkova NJ, Merkulov S, McCrae K, Russek SE, Banda NK, Simberg D. High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties. ACS Nano 2014;8:12437-49. [PMID: 25419856 DOI: 10.1021/nn505126b] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
10 Liu S, Li D, Zhang Z, Surya Prakash GK, Conti PS, Li Z. Efficient synthesis of fluorescent-PET probes based on [¹⁸F]BODIPY dye. Chem Commun (Camb) 2014;50:7371-3. [PMID: 24869927 DOI: 10.1039/c4cc01411a] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
11 Chen H, Zhen Z, Todd T, Chu PK, Xie J. Nanoparticles for Improving Cancer Diagnosis. Mater Sci Eng R Rep 2013;74:35-69. [PMID: 24068857 DOI: 10.1016/j.mser.2013.03.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
12 Zhang Y, Hong H, Cai W. Photoacoustic imaging. Cold Spring Harb Protoc 2011;2011:pdb. [PMID: 21880823 DOI: 10.1101/pdb.top065508] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
13 Kircher MF, Hricak H, Larson SM. Molecular imaging for personalized cancer care. Mol Oncol 2012;6:182-95. [PMID: 22469618 DOI: 10.1016/j.molonc.2012.02.005] [Cited by in Crossref: 113] [Cited by in F6Publishing: 83] [Article Influence: 11.3] [Reference Citation Analysis]
14 Liu Q, Li C, Liu J, Krish K, Fu X, Zhao J, Chen JC. Technical Note: Performance evaluation of a small-animal PET/CT system based on NEMA NU 4-2008 standards. Med Phys 2021. [PMID: 34252215 DOI: 10.1002/mp.15088] [Reference Citation Analysis]
15 Eder M, Krivoshein AV, Backer M, Backer JM, Haberkorn U, Eisenhut M. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature. Nucl Med Biol 2010;37:405-12. [PMID: 20447550 DOI: 10.1016/j.nucmedbio.2010.02.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
16 García-figueiras R, Padhani AR, Beer AJ, Baleato-gonzález S, Vilanova JC, Luna A, Oleaga L, Gómez-caamaño A, Koh D. Imaging of Tumor Angiogenesis for Radiologists—Part 1: Biological and Technical Basis. Current Problems in Diagnostic Radiology 2015;44:407-24. [DOI: 10.1067/j.cpradiol.2015.02.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
17 Ai F, Ferreira CA, Chen F, Cai W. Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016;8:619-30. [PMID: 26692551 DOI: 10.1002/wnan.1386] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
18 Hou S, Phung DL, Lin WY, Wang MW, Liu K, Shen CK. Microwave-assisted one-pot synthesis of N-succinimidyl-4[ ¹⁸F]fluorobenzoate ([¹⁸F]SFB). J Vis Exp 2011:2755. [PMID: 21730951 DOI: 10.3791/2755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
19 Fu H, Sa R, Cheng L, Jin Y, Qiu X, Liu M, Chen L. Updated Review of Nuclear Molecular Imaging of Thyroid Cancers. Endocr Pract 2021;27:494-502. [PMID: 33934754 DOI: 10.1016/j.eprac.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Denbeigh JM, Nixon BA, Lee JJ, Jerkic M, Marsden PA, Letarte M, Puri MC, Foster FS. Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. Angiogenesis 2015;18:69-81. [PMID: 25298070 DOI: 10.1007/s10456-014-9447-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Chakraborty S, Chakravarty R, Sarma HD, Dash A, Pillai M. The Practicality of Nanoceria-PAN-Based 68 Ge/ 68 Ga Generator Toward Preparation of 68 Ga-Labeled Cyclic RGD Dimer as a Potential PET Radiotracer for Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals 2013;28:77-83. [DOI: 10.1089/cbr.2012.1252] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
22 Soliman MA, Guccione J, Reiter AM, Moawad AW, Etchison A, Kamel S, Khatchikian AD, Elsayes KM. Current Concepts in Multi-Modality Imaging of Solid Tumor Angiogenesis. Cancers (Basel) 2020;12:E3239. [PMID: 33153067 DOI: 10.3390/cancers12113239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Dominietto M, Lehmann S, Keist R, Rudin M. Pattern analysis accounts for heterogeneity observed in MRI studies of tumor angiogenesis. Magn Reson Med. 2013;70:1481-1490. [PMID: 23280475 DOI: 10.1002/mrm.24590] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
24 Kostiv U, Lobaz V, Kučka J, Švec P, Sedláček O, Hrubý M, Janoušková O, Francová P, Kolářová V, Šefc L, Horák D. A simple neridronate-based surface coating strategy for upconversion nanoparticles: highly colloidally stable 125 I-radiolabeled NaYF 4 :Yb 3+ /Er 3+ @PEG nanoparticles for multimodal in vivo tissue imaging. Nanoscale 2017;9:16680-8. [DOI: 10.1039/c7nr05456d] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 7.4] [Reference Citation Analysis]
25 Parashurama N, O'Sullivan TD, De La Zerda A, El Kalassi P, Cho S, Liu H, Teed R, Levy H, Rosenberg J, Cheng Z, Levi O, Harris JS, Gambhir SS. Continuous sensing of tumor-targeted molecular probes with a vertical cavity surface emitting laser-based biosensor. J Biomed Opt 2012;17:117004. [PMID: 23123976 DOI: 10.1117/1.JBO.17.11.117004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Orbay H, Hong H, Zhang Y, Cai W. PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow. Angiogenesis 2013;16:279-87. [PMID: 23117521 DOI: 10.1007/s10456-012-9319-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
27 Iqbal U, Albaghdadi H, Nieh MP, Tuor UI, Mester Z, Stanimirovic D, Katsaras J, Abulrob A. Small unilamellar vesicles: a platform technology for molecular imaging of brain tumors. Nanotechnology 2011;22:195102. [PMID: 21436507 DOI: 10.1088/0957-4484/22/19/195102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
28 Deshpande N, Pysz MA, Willmann JK. Molecular ultrasound assessment of tumor angiogenesis. Angiogenesis 2010;13:175-88. [PMID: 20549555 DOI: 10.1007/s10456-010-9175-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
29 Diana D, Di Stasi R, De Rosa L, Isernia C, D'andrea LD, Fattorusso R. Structural investigation of the VEGF receptor interaction with a helical antagonist peptide: STRUCTURAL STUDIES OF VEGF RECEPTOR BOUND TO AN ANTAGONIST PEPTIDE. J Pept Sci 2013;19:214-9. [DOI: 10.1002/psc.2480] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
30 Hong H, Zhang Y, Sun J, Cai W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 2009;4:399-413. [PMID: 20161038 DOI: 10.1016/j.nantod.2009.07.001] [Cited by in Crossref: 163] [Cited by in F6Publishing: 148] [Article Influence: 12.5] [Reference Citation Analysis]
31 Zhou C, Hao G, Thomas P, Liu J, Yu M, Sun S, Öz OK, Sun X, Zheng J. Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics. Angew Chem Int Ed Engl. 2012;51:10118-10122. [PMID: 22961978 DOI: 10.1002/anie.201203031] [Cited by in Crossref: 135] [Cited by in F6Publishing: 121] [Article Influence: 13.5] [Reference Citation Analysis]
32 Chen B, Cao S, Zhang Y, Wang X, Liu J, Hui X, Wan Y, Du W, Wang L, Wu K, Fan D. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy. BMC Cell Biol 2009;10:63. [PMID: 19740430 DOI: 10.1186/1471-2121-10-63] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
33 Mahmoudi M, Serpooshan V, Laurent S. Engineered nanoparticles for biomolecular imaging. Nanoscale 2011;3:3007. [DOI: 10.1039/c1nr10326a] [Cited by in Crossref: 202] [Cited by in F6Publishing: 175] [Article Influence: 18.4] [Reference Citation Analysis]
34 Galli F, Artico M, Taurone S, Manni I, Bianchi E, Piaggio G, Weintraub BD, Szkudlinski MW, Agostinelli E, Dierckx RAJO, Signore A. Radiolabeling of VEGF165 with 99mTc to evaluate VEGFR expression in tumor angiogenesis. Int J Oncol 2017;50:2171-9. [PMID: 28498441 DOI: 10.3892/ijo.2017.3989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Goel S, Chen F, Hong H, Valdovinos HF, Hernandez R, Shi S, Barnhart TE, Cai W. VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system. ACS Appl Mater Interfaces 2014;6:21677-85. [PMID: 25353068 DOI: 10.1021/am506849p] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
36 Zhang L, Zhou H, Belzile O, Thorpe P, Zhao D. Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. J Control Release 2014;183:114-23. [PMID: 24698945 DOI: 10.1016/j.jconrel.2014.03.043] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
37 Blasiak B, Landry J, Tyson R, Sharp J, Iqbal U, Abulrob A, Rushforth D, Matyas J, Ponjevic D, Sutherland GR, Wolfsberger S, Tomanek B. Molecular susceptibility weighted imaging of the glioma rim in a mouse model. Journal of Neuroscience Methods 2014;226:132-8. [DOI: 10.1016/j.jneumeth.2014.01.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
38 Hong H, Severin GW, Yang Y, Engle JW, Zhang Y, Barnhart TE, Liu G, Leigh BR, Nickles RJ, Cai W. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. Eur J Nucl Med Mol Imaging 2012;39:138-48. [PMID: 21909753 DOI: 10.1007/s00259-011-1930-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
39 Burke BP, Cawthorne C, Archibald SJ. Multimodal nanoparticle imaging agents: design and applications. Philos Trans A Math Phys Eng Sci 2017;375:20170261. [PMID: 29038384 DOI: 10.1098/rsta.2017.0261] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
40 Zhang Q, Du Y, Xue Z, Chi C, Jia X, Tian J. Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging. PLoS One. 2014;9:e85559. [PMID: 24416426 DOI: 10.1371/journal.pone.0085559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
41 Zrazhevskiy P, Sena M, Gao X. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev. 2010;39:4326-4354. [PMID: 20697629 DOI: 10.1039/b915139g] [Cited by in Crossref: 715] [Cited by in F6Publishing: 606] [Article Influence: 59.6] [Reference Citation Analysis]
42 Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol. 2010;65:500-516. [PMID: 20541650 DOI: 10.1016/j.crad.2010.03.011] [Cited by in Crossref: 334] [Cited by in F6Publishing: 286] [Article Influence: 27.8] [Reference Citation Analysis]
43 Yuan B, Rychak J. Tumor functional and molecular imaging utilizing ultrasound and ultrasound-mediated optical techniques. Am J Pathol 2013;182:305-11. [PMID: 23219728 DOI: 10.1016/j.ajpath.2012.07.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
44 Yang G, Nie P, Kong Y, Sun H, Hou G, Han J. MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice. Tumour Biol 2015;36:3285-91. [PMID: 25501513 DOI: 10.1007/s13277-014-2958-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
45 Liu Y, Chen S, Sun J, Zhu S, Chen C, Xie W, Zheng J, Zhu Y, Xiao L, Hao L, Wang Z, Chang S. Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo. Mol Pharm 2019;16:4104-20. [PMID: 31517495 DOI: 10.1021/acs.molpharmaceut.9b00339] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
46 Yang S, Chen C, Qiu Y, Xu C, Yao J. Paying attention to tumor blood vessels: Cancer phototherapy assisted with nano delivery strategies. Biomaterials 2021;268:120562. [PMID: 33278682 DOI: 10.1016/j.biomaterials.2020.120562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shi J, Wang F, Liu S. Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging. Biophys Rep 2016;2:1-20. [PMID: 27819026 DOI: 10.1007/s41048-016-0021-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
48 Rezazadeh F, Sadeghzadeh N, Abedi SM, Abediankenari S. 99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging. Nucl Med Biol 2018;62-63:54-62. [PMID: 29885559 DOI: 10.1016/j.nucmedbio.2018.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
49 Hong H, Sun J, Cai W. Multimodality imaging of nitric oxide and nitric oxide synthases. Free Radic Biol Med 2009;47:684-98. [PMID: 19524664 DOI: 10.1016/j.freeradbiomed.2009.06.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
50 Hong H, Goel S, Zhang Y, Cai W. Molecular imaging with nucleic acid aptamers. Curr Med Chem 2011;18:4195-205. [PMID: 21838686 DOI: 10.2174/092986711797189691] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
51 Zhou Y, Shao G, Liu S. Monitoring Breast Tumor Lung Metastasis by U-SPECT-II/CT with an Integrin α(v)β(3)-Targeted Radiotracer( 99m)Tc-3P-RGD(2). Theranostics 2012;2:577-88. [PMID: 22737193 DOI: 10.7150/thno.4443] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
52 Wang HW, Jiang JK, Lin CH, Lin JK, Huang GJ, Yu JS. Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors. Opt Express. 2009;17:2805-2817. [PMID: 19219185 DOI: 10.1364/oe.17.002805] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
53 Sun W, Sun Y, Klar AS, Geutjes P, Reichmann E, Heerschap A, Oosterwijk E. Functional Analysis of Vascularized Collagen/Fibrin Templates by MRI In Vivo. Tissue Eng Part C Methods 2016;22:747-55. [PMID: 27324220 DOI: 10.1089/ten.TEC.2016.0035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Diaz R, Passarella RJ, Hallahan DE. Determining glioma response to radiation therapy using recombinant peptides. Expert Rev Anticancer Ther 2008;8:1787-96. [PMID: 18983239 DOI: 10.1586/14737140.8.11.1787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
55 Choyke PL. Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins? Radiology 2011;260:1-2. [PMID: 21697304 DOI: 10.1148/radiol.11110740] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
56 Shi J, Zhou Y, Chakraborty S, Kim YS, Jia B, Wang F, Liu S. Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability. Theranostics 2011;1:322-40. [PMID: 21850213 DOI: 10.7150/thno/v01p0322] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
57 Fu T, Chen Y, Hao J, Wang X, Liu G, Li Y, Liu Z, Cheng L. Facile preparation of uniform FeSe2 nanoparticles for PA/MR dual-modal imaging and photothermal cancer therapy. Nanoscale 2015;7:20757-68. [PMID: 26603315 DOI: 10.1039/c5nr06840a] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 5.3] [Reference Citation Analysis]
58 Jain A, Chakraborty S, Sarma HD, Dash A. A Systematic Comparative Evaluation of 68Ga-Labeled RGD Peptides Conjugated with Different Chelators. Nucl Med Mol Imaging 2018;52:125-34. [PMID: 29662561 DOI: 10.1007/s13139-017-0499-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Steinberg JD, Raju A, Chandrasekharan P, Yang CT, Khoo K, Abastado JP, Robins EG, Townsend DW. Negative contrast Cerenkov luminescence imaging of blood vessels in a tumor mouse model using [68Ga]gallium chloride. EJNMMI Res 2014;4:15. [PMID: 24606872 DOI: 10.1186/2191-219X-4-15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Akers WJ, Zhang Z, Berezin M, Ye Y, Agee A, Guo K, Fuhrhop RW, Wickline SA, Lanza GM, Achilefu S. Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles. Nanomedicine (Lond) 2010;5:715-26. [PMID: 20662643 DOI: 10.2217/nnm.10.38] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
61 Lee S, Chen X. Dual-Modality Probes for in Vivo Molecular Imaging. Mol Imaging 2009;8:7290.2009.00013. [DOI: 10.2310/7290.2009.00013] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
62 Macías MT. Use of radionuclides in cancer research and treatment. Clin Transl Oncol 2009;11:143-53. [PMID: 19293051 DOI: 10.1007/s12094-009-0330-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Liu Y, Yuan B, Vignola J. Effect of fluorescent particle size on the modulation efficiency of ultrasound-modulated fluorescence. Int J Opt 2012;2012. [PMID: 24179476 DOI: 10.1155/2012/260709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
64 Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao H, Liu Z, Wang F, Chen X, Liu S. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Mol Pharm 2009;6:231-45. [PMID: 19067525 DOI: 10.1021/mp800150r] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
65 Hong H, Zhang Y, Cai W. In vivo imaging of RNA interference. J Nucl Med. 2010;51:169-172. [PMID: 20080892 DOI: 10.2967/jnumed.109.066878] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
66 Fang C, Veiseh O, Kievit F, Bhattarai N, Wang F, Stephen Z, Li C, Lee D, Ellenbogen RG, Zhang M. Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior. Nanomedicine (Lond) 2010;5:1357-69. [PMID: 21128719 DOI: 10.2217/nnm.10.55] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
67 Wang Y, Chen C, Luo Y, Xiong J, Tang Y, Yang H, Wang L, Jiang F, Gao X, Xu D, Li H, Wang Q, Zou J. Experimental Study of Tumor Therapy Mediated by Multimodal Imaging Based on a Biological Targeting Synergistic Agent. Int J Nanomedicine 2020;15:1871-88. [PMID: 32256065 DOI: 10.2147/IJN.S238398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, Scheinberg DA, McDevitt MR. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. Int J Nanomedicine 2010;5:783-802. [PMID: 21042424 DOI: 10.2147/IJN.S13300] [Cited by in Crossref: 16] [Cited by in F6Publishing: 53] [Article Influence: 1.3] [Reference Citation Analysis]
69 Pillai MRA, Nanabala R, Joy A, Sasikumar A, Russ Knapp FF. Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer. Nucl Med Biol 2016;43:692-720. [PMID: 27589333 DOI: 10.1016/j.nucmedbio.2016.08.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
70 Mehta A, Ghaghada K, Mukundan S Jr. Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles. Magn Reson Imaging Clin N Am 2016;24:751-63. [PMID: 27742115 DOI: 10.1016/j.mric.2016.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Ni D, Jiang D, Ehlerding EB, Huang P, Cai W. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications. Acc Chem Res 2018;51:778-88. [PMID: 29489335 DOI: 10.1021/acs.accounts.7b00635] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
72 Prabhakaran J, Arango V, Majo VJ, Simpson NR, Kassir SA, Underwood MD, Polavarapu H, Bruce JN, Canoll P, Mann JJ, Kumar JS. Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2. Bioorg Med Chem Lett 2012;22:5104-7. [PMID: 22749281 DOI: 10.1016/j.bmcl.2012.05.099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
73 Li BN, He PP, Yang PP, Zhang JP, Wang L, Wang H. In situ construction of nanonetworks from transformable nanoparticles for anti-angiogenic therapy. J Mater Chem B 2018;6:5282-9. [PMID: 32254765 DOI: 10.1039/c8tb00974k] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Simões JCS, Sarpaki S, Papadimitroulas P, Therrien B, Loudos G. Conjugated Photosensitizers for Imaging and PDT in Cancer Research. J Med Chem 2020;63:14119-50. [PMID: 32990442 DOI: 10.1021/acs.jmedchem.0c00047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
75 Samén E, Thorell JO, Lu L, Tegnebratt T, Holmgren L, Stone-Elander S. Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2. Eur J Nucl Med Mol Imaging 2009;36:1283-95. [PMID: 19288096 DOI: 10.1007/s00259-009-1111-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
76 Zhang J, Hao G, Yao C, Yu J, Wang J, Yang W, Hu C, Zhang B. Albumin-Mediated Biomineralization of Paramagnetic NIR Ag 2 S QDs for Tiny Tumor Bimodal Targeted Imaging in Vivo. ACS Appl Mater Interfaces 2016;8:16612-21. [DOI: 10.1021/acsami.6b04738] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
77 Dai Y, Chen X, Yin J, Kang X, Wang G, Zhang X, Nie Y, Wu K, Liang J. Investigation of injection dose and camera integration time on quantifying pharmacokinetics of a Cy5.5-GX1 probe with dynamic fluorescence imaging in vivo. J Biomed Opt 2016;21:086001. [DOI: 10.1117/1.jbo.21.8.086001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
78 Liu J, Fan W, Liu M, Lin X, Wang Y, Wang F, Chen X, Cao F, Liang J. Spatial vascular volume fraction imaging for quantitative assessment of angiogenesis. Mol Imaging Biol 2014;16:362-71. [PMID: 24158404 DOI: 10.1007/s11307-013-0694-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
79 Waerzeggers Y, Monfared P, Viel T, Faust A, Kopka K, Schäfers M, Tavitian B, Winkeler A, Jacobs A. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments. Br J Radiol 2011;84 Spec No 2:S168-78. [PMID: 22433827 DOI: 10.1259/bjr/66405626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Hong H, Sun J, Cai W. Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. Biomark Insights 2008;3:435-51. [PMID: 19578524 DOI: 10.4137/bmi.s1124] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
81 Yang CT, Ghosh KK, Padmanabhan P, Langer O, Liu J, Eng DNC, Halldin C, Gulyás B. PET-MR and SPECT-MR multimodality probes: Development and challenges. Theranostics 2018;8:6210-32. [PMID: 30613293 DOI: 10.7150/thno.26610] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
82 Shi J, Kim YS, Zhai S, Liu Z, Chen X, Liu S. Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers. Bioconjug Chem 2009;20:750-9. [PMID: 19320477 DOI: 10.1021/bc800455p] [Cited by in Crossref: 105] [Cited by in F6Publishing: 109] [Article Influence: 8.1] [Reference Citation Analysis]
83 Sun Y, Zhu X, Peng J, Li F. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. ACS Nano 2013;7:11290-300. [PMID: 24205939 DOI: 10.1021/nn405082y] [Cited by in Crossref: 212] [Cited by in F6Publishing: 177] [Article Influence: 23.6] [Reference Citation Analysis]
84 Hasman A, Ammenwerth E, Dickhaus H, Knaup P, Lovis C, Mantas J, Maojo V, Martin-Sanchez FJ, Musen M, Patel VL, Surjan G, Talmon JL, Sarkar IN. Biomedical informatics--a confluence of disciplines? Methods Inf Med 2011;50:508-24. [PMID: 22146914 DOI: 10.3414/ME11-06-0003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
85 Orbay H, Zhang Y, Hong H, Hacker TA, Valdovinos HF, Zagzebski JA, Theuer CP, Barnhart TE, Cai W. Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105. Mol Pharm 2013;10:2749-56. [PMID: 23738915 DOI: 10.1021/mp400191w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
86 Liu Y, Feshitan JA, Wei MY, Borden MA, Yuan B. Ultrasound-modulated fluorescence based on fluorescent microbubbles. J Biomed Opt 2014;19:085005. [PMID: 25104407 DOI: 10.1117/1.JBO.19.8.085005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
87 Chen K, Xie J, Xu H, Behera D, Michalski MH, Biswal S, Wang A, Chen X. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009;30:6912-9. [PMID: 19773081 DOI: 10.1016/j.biomaterials.2009.08.045] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 8.2] [Reference Citation Analysis]
88 Hong H, Gao T, Cai W. Molecular Imaging with Single-Walled Carbon Nanotubes. Nano Today 2009;4:252-61. [PMID: 21754949 DOI: 10.1016/j.nantod.2009.04.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 75] [Article Influence: 7.3] [Reference Citation Analysis]
89 Majkić-singh N. What is a Biomarker? From its Discovery to Clinical Application. Journal of Medical Biochemistry 2011;30:186-92. [DOI: 10.2478/v10011-011-0029-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
90 Bavelaar BM, Lee BQ, Gill MR, Falzone N, Vallis KA. Subcellular Targeting of Theranostic Radionuclides. Front Pharmacol 2018;9:996. [PMID: 30233374 DOI: 10.3389/fphar.2018.00996] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
91 Chakraborty S, Chakravarty R, Vatsa R, Bhusari P, Sarma HD, Shukla J, Mittal BR, Dash A. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative. Nucl Med Biol 2016;43:116-23. [PMID: 26527030 DOI: 10.1016/j.nucmedbio.2015.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
92 Di stasi R, Diana D, Capasso D, Di gaetano S, De rosa L, Celentano V, Isernia C, Fattorusso R, D'andrea LD. VEGFR Recognition Interface of a Proangiogenic VEGF-Mimetic Peptide Determined In Vitro and in the Presence of Endothelial Cells by NMR Spectroscopy. Chem Eur J 2018;24:11461-6. [DOI: 10.1002/chem.201802117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
93 Chakraborty S, Sarma H, Vimalnath K, Pillai M. Tracer level radiochemistry to clinical dose preparation of 177Lu-labeled cyclic RGD peptide dimer. Nuclear Medicine and Biology 2013;40:946-54. [DOI: 10.1016/j.nucmedbio.2013.05.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
94 Huang J, Guo M, Ke H, Zong C, Ren B, Liu G, Shen H, Ma Y, Wang X, Zhang H, Deng Z, Chen H, Zhang Z. Rational Design and Synthesis of γFe2 O3 @Au Magnetic Gold Nanoflowers for Efficient Cancer Theranostics. Adv Mater 2015;27:5049-56. [PMID: 26198387 DOI: 10.1002/adma.201501942] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 14.9] [Reference Citation Analysis]
95 Wolf G, Abolmaali N. Preclinical molecular imaging using PET and MRI. Recent Results Cancer Res. 2013;187:257-310. [PMID: 23179885 DOI: 10.1007/978-3-642-10853-2_9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
96 Zhang Y, Yang Y, Cai W. Multimodality Imaging of Integrin α(v)β(3) Expression. Theranostics 2011;1:135-48. [PMID: 21547156 DOI: 10.7150/thno/v01p0135] [Cited by in Crossref: 30] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
97 Sun X, Yan Y, Liu S, Cao Q, Yang M, Neamati N, Shen B, Niu G, Chen X. 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy. J Nucl Med 2011;52:140-6. [PMID: 21149494 DOI: 10.2967/jnumed.110.080606] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
98 Laudicella R, Quartuccio N, Argiroffi G, Alongi P, Baratto L, Califaretti E, Frantellizzi V, De Vincentis G, Del Sole A, Evangelista L, Baldari S, Bisdas S, Ceci F, Iagaru A; Young Italian Association of Nuclear Medicine (AIMN) group. Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas. Eur J Nucl Med Mol Imaging 2021. [PMID: 33851243 DOI: 10.1007/s00259-021-05352-w] [Reference Citation Analysis]
99 Liu Z, Yan Y, Liu S, Wang F, Chen X. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Bioconjug Chem 2009;20:1016-25. [PMID: 20540537 DOI: 10.1021/bc9000245] [Cited by in Crossref: 106] [Cited by in F6Publishing: 101] [Article Influence: 8.8] [Reference Citation Analysis]
100 Cheng B, Wei MY, Liu Y, Pitta H, Xie Z, Hong Y, Nguyen KT, Yuan B. Development of Ultrasound-switchable Fluorescence Imaging Contrast Agents based on Thermosensitive Polymers and Nanoparticles. IEEE J Sel Top Quantum Electron 2014;20:6801214. [PMID: 26052192 DOI: 10.1109/JSTQE.2013.2280997] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
101 Rybalov M, Ananias HJ, Hoving HD, van der Poel HG, Rosati S, de Jong IJ. PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy. Int J Mol Sci 2014;15:6046-61. [PMID: 24727373 DOI: 10.3390/ijms15046046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
102 Patel AR, Lim E, Francis KP, Singh M. Opening up the optical imaging window using nano-luciferin. Pharm Res 2014;31:3073-84. [PMID: 24831312 DOI: 10.1007/s11095-014-1400-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
103 Zhang CC, Yan Z, Giddabasappa A, Lappin PB, Painter CL, Zhang Q, Li G, Goodman J, Simmons B, Pascual B. Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib. Cancer Med. 2014;3:462-471. [PMID: 24573979 DOI: 10.1002/cam4.215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
104 Hong H, Wang F, Zhang Y, Graves SA, Eddine SB, Yang Y, Theuer CP, Nickles RJ, Wang X, Cai W. Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting. ACS Appl Mater Interfaces 2015;7:3373-81. [PMID: 25607242 DOI: 10.1021/am508440j] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
105 Kim MH, Kim CG, Kim SG, Kim DW. A novel Tc-99 m and fluorescence labeled peptide as a multimodal imaging agent for targeting angiogenesis in a murine tumor model. Contrast Media Mol Imaging 2016;11:527-34. [PMID: 27739174 DOI: 10.1002/cmmi.1714] [Reference Citation Analysis]
106 Cheng L, Shen S, Shi S, Yi Y, Wang X, Song G, Yang K, Liu G, Barnhart TE, Cai W, Liu Z. FeSe2-Decorated Bi2Se3 Nanosheets Fabricated via Cation Exchange for Chelator-Free 64Cu-labeling and Multimodal Image-Guided Photothermal-Radiation Therapy. Adv Funct Mater 2016;26:2185-97. [PMID: 27110230 DOI: 10.1002/adfm.201504810] [Cited by in Crossref: 184] [Cited by in F6Publishing: 170] [Article Influence: 30.7] [Reference Citation Analysis]
107 Dai Y, Yin J, Huang Y, Chen X, Wang G, Liu Y, Zhang X, Nie Y, Wu K, Liang J. In vivo quantifying molecular specificity of Cy5.5-labeled cyclic 9-mer peptide probe with dynamic fluorescence imaging. Biomed Opt Express 2016;7:1149-59. [PMID: 27446643 DOI: 10.1364/BOE.7.001149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
108 Gupta AS, von Recum HA. Bioconjugation Strategies: Lipids, Liposomes, Polymersomes, and Microbubbles. In: Narain R, editor. Chemistry of Bioconjugates. Hoboken: John Wiley & Sons, Inc.; 2014. pp. 185-202. [DOI: 10.1002/9781118775882.ch6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
109 Koziolová E, Goel S, Chytil P, Janoušková O, Barnhart TE, Cai W, Etrych T. A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging. Nanoscale 2017;9:10906-18. [PMID: 28731080 DOI: 10.1039/c7nr03306k] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
110 Kim C, Song HM, Cai X, Yao J, Wei A, Wang LV. In vivo photoacoustic mapping of lymphatic systems with plasmon-resonant nanostars. J Mater Chem 2011;21:2841-4. [PMID: 21660122 DOI: 10.1039/C0JM04194G] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 7.4] [Reference Citation Analysis]
111 Scheinberg DA, Villa CH, Escorcia FE, McDevitt MR. Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nat Rev Clin Oncol 2010;7:266-76. [PMID: 20351700 DOI: 10.1038/nrclinonc.2010.38] [Cited by in Crossref: 142] [Cited by in F6Publishing: 134] [Article Influence: 11.8] [Reference Citation Analysis]
112 Guo W, Sun X, Jacobson O, Yan X, Min K, Srivatsan A, Niu G, Kiesewetter DO, Chang J, Chen X. Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence. ACS Nano 2015;9:488-95. [PMID: 25549258 DOI: 10.1021/nn505660r] [Cited by in Crossref: 107] [Cited by in F6Publishing: 101] [Article Influence: 15.3] [Reference Citation Analysis]
113 Silindir M, Erdoğan S, Özer AY, Doğan AL, Tuncel M, Uğur Ö, Torchilin VP. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT. J Liposome Res 2013;23:20-7. [PMID: 23078019 DOI: 10.3109/08982104.2012.722107] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
114 Fan CH, Ting CY, Liu HL, Huang CY, Hsieh HY, Yen TC, Wei KC, Yeh CK. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 2013;34:2142-55. [PMID: 23246066 DOI: 10.1016/j.biomaterials.2012.11.048] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 9.2] [Reference Citation Analysis]
115 Zhou Z, Huang D, Bao J, Chen Q, Liu G, Chen Z, Chen X, Gao J. A synergistically enhanced T(1) -T(2) dual-modal contrast agent. Adv Mater 2012;24:6223-8. [PMID: 22972529 DOI: 10.1002/adma.201203169] [Cited by in Crossref: 205] [Cited by in F6Publishing: 188] [Article Influence: 20.5] [Reference Citation Analysis]
116 Cyran CC, von Einem JC, Paprottka PM, Schwarz B, Ingrisch M, Dietrich O, Hinkel R, Bruns CJ, Clevert DA, Eschbach R, Reiser MF, Wintersperger BJ, Nikolaou K. Dynamic Contrast-Enhanced Computed Tomography Imaging Biomarkers Correlated With Immunohistochemistry for Monitoring the Effects of Sorafenib on Experimental Prostate Carcinomas: . Investigative Radiology 2012;47:49-57. [DOI: 10.1097/rli.0b013e3182300fe4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
117 Mulder WJ, Griffioen AW. Imaging of angiogenesis. Angiogenesis 2010;13:71-4. [PMID: 20559867 DOI: 10.1007/s10456-010-9178-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
118 Liu Z, Shi J, Jia B, Yu Z, Liu Y, Zhao H, Li F, Tian J, Chen X, Liu S, Wang F. Two 90 Y-Labeled Multimeric RGD Peptides RGD4 and 3PRGD2 for Integrin Targeted Radionuclide Therapy. Mol Pharmaceutics 2011;8:591-9. [DOI: 10.1021/mp100403y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
119 Ji S, Zheng Y, Shao G, Zhou Y, Liu S. Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy. Theranostics 2013;3:816-30. [PMID: 24312152 DOI: 10.7150/thno.6989] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
120 Ribatti D, Solimando AG, Pezzella F. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers (Basel) 2021;13:3433. [PMID: 34298648 DOI: 10.3390/cancers13143433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Li J, Zhang C, Yang K, Liu P, Xu LX. SPIO-RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation. J Synchrotron Radiat 2011;18:612-6. [PMID: 21685679 DOI: 10.1107/S090904951101017X] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Liu Z, Niu G, Shi J, Liu S, Wang F, Liu S, Chen X. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. Eur J Nucl Med Mol Imaging 2009;36:947-57. [PMID: 19159928 DOI: 10.1007/s00259-008-1045-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 8.2] [Reference Citation Analysis]
123 Zhang R, Huang G, Chen L, Wu W. Studies on the Conformations and Hydrogen-Bonding Interactions of RGD Tri-peptide in Aqueous Solutions by Molecular Dynamics Simulations and 2D-NOESY Spectroscopy. J Solution Chem 2015;44:1281-91. [DOI: 10.1007/s10953-015-0333-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
124 Wong FC, Kim EE. A review of molecular imaging studies reaching the clinical stage. European Journal of Radiology 2009;70:205-11. [DOI: 10.1016/j.ejrad.2009.01.049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
125 Mahajan A, Goh V, Basu S, Vaish R, Weeks AJ, Thakur MH, Cook GJ. Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine? Clin Radiol. 2015;70:1060-1082. [PMID: 26187890 DOI: 10.1016/j.crad.2015.06.082] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
126 Waerzeggers Y, Ullrich RT, Monfared P, Viel T, Weckesser M, Stummer W, Schober O, Winkeler A, Jacobs AH. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. Br J Radiol 2011;84 Spec No 2:S179-95. [PMID: 22433828 DOI: 10.1259/bjr/76389842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
127 Chuang YJ, Zhen Z, Zhang F, Liu F, Mishra JP, Tang W, Chen H, Huang X, Wang L, Chen X, Xie J, Pan Z. Photostimulable near-infrared persistent luminescent nanoprobes for ultrasensitive and longitudinal deep-tissue bio-imaging. Theranostics 2014;4:1112-22. [PMID: 25285164 DOI: 10.7150/thno.9710] [Cited by in F6Publishing: 60] [Reference Citation Analysis]
128 Martin AL, Hickey JL, Ablack AL, Lewis JD, Luyt LG, Gillies ER. Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells. J Nanopart Res 2009;12:1599-608. [PMID: 22328862 DOI: 10.1007/s11051-009-9681-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
129 Mansi L, Virgolini I. Diagnosis and therapy are walking together on radiopeptides' avenue. Eur J Nucl Med Mol Imaging 2011;38:605-12. [PMID: 21365250 DOI: 10.1007/s00259-011-1762-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
130 Pan H, Myerson JW, Ivashyna O, Soman NR, Marsh JN, Hood JL, Lanza GM, Schlesinger PH, Wickline SA. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J 2010;24:2928-37. [PMID: 20335225 DOI: 10.1096/fj.09-153130] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
131 Cai H, Conti PS. RGD-based PET tracers for imaging receptor integrin αv β3 expression. J Labelled Comp Radiopharm 2013;56:264-79. [PMID: 24285371 DOI: 10.1002/jlcr.2999] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
132 Macis G, Di Giovanni S, Di Franco D, Bonomo L. Future Perspectives for Diagnostic Imaging in Urology: From Anatomic and Functional to Molecular Imaging. Urologia 2013;80:29-41. [DOI: 10.5301/ru.2013.10792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
133 Shi J, Wang L, Kim Y, Zhai S, Jia B, Wang F, Liu S. 99mTcO(MAG2-3G3-dimer): a new integrin αvβ3-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics. Eur J Nucl Med Mol Imaging 2009;36:1874-84. [DOI: 10.1007/s00259-009-1166-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
134 Madru R, Svenmarker P, Ingvar C, Ståhlberg F, Engels SA, Knutsson L, Strand SE. Development of a Hybrid Nanoprobe for Triple-Modality MR/SPECT/Optical Fluorescence Imaging. Diagnostics (Basel) 2014;4:13-26. [PMID: 26852675 DOI: 10.3390/diagnostics4010013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
135 Zhou Y, Han X, Jing X, Chen Y. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine. Adv Healthcare Mater 2017;6:1700646. [DOI: 10.1002/adhm.201700646] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
136 Kim MH, Kim S, Kim D. A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model. J Label Compd Radiopharm 2018;61:557-66. [DOI: 10.1002/jlcr.3625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
137 Gambhir SS. Molecualr imaging of cancer: from molecules to humans. Introduction. J Nucl Med 2008;49 Suppl 2:1S-4S. [PMID: 18523062 DOI: 10.2967/jnumed.108.053751] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
138 Zhang F, Niu G, Lu G, Chen X. Preclinical lymphatic imaging. Mol Imaging Biol 2011;13:599-612. [PMID: 20862613 DOI: 10.1007/s11307-010-0421-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
139 Reichardt W, von Elverfeldt D. Preclinical Applications of Magnetic Resonance Imaging in Oncology. Recent Results Cancer Res 2020;216:405-37. [PMID: 32594394 DOI: 10.1007/978-3-030-42618-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Yang X, Hong H, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Xiao Y, Yang Y, Zhang Y, Nickles RJ. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials. 2011;32:4151-4160. [PMID: 21367450 DOI: 10.1016/j.biomaterials.2011.02.006] [Cited by in Crossref: 304] [Cited by in F6Publishing: 256] [Article Influence: 27.6] [Reference Citation Analysis]
141 Chen F, Valdovinos HF, Hernandez R, Goel S, Barnhart TE, Cai W. Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles. Acta Pharmacol Sin 2017;38:907-13. [PMID: 28414201 DOI: 10.1038/aps.2017.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
142 Shi S, Fliss BC, Gu Z, Zhu Y, Hong H, Valdovinos HF, Hernandez R, Goel S, Luo H, Chen F, Barnhart TE, Nickles RJ, Xu ZP, Cai W. Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging. Sci Rep 2015;5:16930. [PMID: 26585551 DOI: 10.1038/srep16930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
143 Buckle T, van Willigen DM, Spa SJ, Hensbergen AW, van der Wal S, de Korne CM, Welling MM, van der Poel HG, Hardwick JCH, van Leeuwen FWB. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer. J Nucl Med 2018;59:986-92. [PMID: 29449447 DOI: 10.2967/jnumed.117.205575] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
144 Mukherjee S, Sonanini D, Maurer A, Daldrup-Link HE. The yin and yang of imaging tumor associated macrophages with PET and MRI. Theranostics 2019;9:7730-48. [PMID: 31695797 DOI: 10.7150/thno.37306] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
145 Michalski MH, Chen X. Molecular imaging in cancer treatment. Eur J Nucl Med Mol Imaging 2011;38:358-77. [PMID: 20661557 DOI: 10.1007/s00259-010-1569-z] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
146 Wei W, Ni D, Ehlerding EB, Luo QY, Cai W. PET Imaging of Receptor Tyrosine Kinases in Cancer. Mol Cancer Ther 2018;17:1625-36. [PMID: 30068751 DOI: 10.1158/1535-7163.MCT-18-0087] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
147 Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Bioconjug Chem 2010;21:1417-24. [PMID: 20666401 DOI: 10.1021/bc900537f] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
148 Dai Y, Chen X, Yin J, Wang G, Wang B, Zhan Y, Nie Y, Wu K, Liang J. Investigation of the influence of sampling schemes on quantitative dynamic fluorescence imaging. Biomed Opt Express 2018;9:1859-70. [PMID: 29675325 DOI: 10.1364/BOE.9.001859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Dasa SS, Jin Q, Chen CT, Chen L. Target-specific copper hybrid T7 phage particles. Langmuir 2012;28:17372-80. [PMID: 23163406 DOI: 10.1021/la3024919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
150 Wang Z, Gao H, Zhang Y, Liu G, Niu G, Chen X. Functional ferritin nanoparticles for biomedical applications. Front Chem Sci Eng 2017;11:633-46. [PMID: 29503759 DOI: 10.1007/s11705-017-1620-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
151 Mees G, Dierckx R, Mertens K, Vermeire S, Van Steenkiste M, Reutelingsperger C, D'asseler Y, Peremans K, Van Damme N, Van de Wiele C. 99m Tc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature. J Nucl Med 2012;53:464-71. [DOI: 10.2967/jnumed.111.095794] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
152 Goel S, Chen F, Luan S, Valdovinos HF, Shi S, Graves SA, Ai F, Barnhart TE, Theuer CP, Cai W. Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies. Adv Sci (Weinh) 2016;3:1600122. [PMID: 27980987 DOI: 10.1002/advs.201600122] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
153 Nougaret S, Guiu B. Antiangiogenic therapy in metastatic renal cell carcinoma: More promises and more challenges for imaging. Diagnostic and Interventional Imaging 2014;95:525-6. [DOI: 10.1016/j.diii.2014.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
154 Kongbundansuk S, Hundley WG. Noninvasive imaging of cardiovascular injury related to the treatment of cancer. JACC Cardiovasc Imaging. 2014;7:824-838. [PMID: 25124015 DOI: 10.1016/j.jcmg.2014.06.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
155 Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010;110:3146-95. [PMID: 20225900 DOI: 10.1021/cr9003538] [Cited by in Crossref: 789] [Cited by in F6Publishing: 713] [Article Influence: 65.8] [Reference Citation Analysis]
156 Wei YC, Gao Y, Zhang J, Fu Z, Zheng J, Liu N, Hu X, Hou W, Yu J, Yuan S. Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model. Sci Rep 2016;6:28757. [PMID: 27350554 DOI: 10.1038/srep28757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
157 Glüer C, Schem C, Tiwari S, Heller M, Jonat W. Molekulare Bildgebung in der gynäkologischen Onkologie. Gynäkologe 2009;42:859-64. [DOI: 10.1007/s00129-009-2420-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Tang L, Sun X, Liu N, Zhou Z, Yu F, Zhang X, Sun X, Chen X. Radiolabeled Angiogenesis-Targeting Croconaine Nanoparticles for Trimodality Imaging Guided Photothermal Therapy of Glioma. ACS Appl Nano Mater 2018;1:1741-9. [PMID: 30506043 DOI: 10.1021/acsanm.8b00195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
159 Penet MF, Chen Z, Bhujwalla ZM. MRI of metastasis-permissive microenvironments. Future Oncol 2011;7:1269-84. [PMID: 22044202 DOI: 10.2217/fon.11.114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
160 Petroni D, Riccardi C, Cavasso D, Russo Krauss I, Paduano L, Montesarchio D, Menichetti L. Synthesis and Characterization of Multifunctional Nanovesicles Composed of POPC Lipid Molecules for Nuclear Imaging. Molecules 2021;26:6591. [PMID: 34770999 DOI: 10.3390/molecules26216591] [Reference Citation Analysis]
161 Rosenkrans ZT, Ferreira CA, Ni D, Cai W. Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer. Adv Healthc Mater 2021;10:e2000690. [PMID: 32691969 DOI: 10.1002/adhm.202000690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
162 Cai W, Gambhir SS, Chen X. Chapter 7. Molecular imaging of tumor vasculature. Methods Enzymol 2008;445:141-76. [PMID: 19022059 DOI: 10.1016/S0076-6879(08)03007-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
163 Zhi D, Yang T, Yang J, Fu S, Zhang S. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Acta Biomaterialia 2020;102:13-34. [DOI: 10.1016/j.actbio.2019.11.027] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 23.5] [Reference Citation Analysis]
164 Zhang Y, Hong H, Engle JW, Yang Y, Theuer CP, Barnhart TE, Cai W. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. Mol Pharm 2012;9:645-53. [PMID: 22292418 DOI: 10.1021/mp200592m] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
165 Hou M, Lai Y, He S, He W, Shen H, Ke Z. SGK3 (CISK) may induce tumor angiogenesis (Hypothesis). Oncol Lett 2015;10:23-6. [PMID: 26170971 DOI: 10.3892/ol.2015.3182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
166 Chen K, Xie J, Chen X. RGD-Human Serum Albumin Conjugates as Efficient Tumor Targeting Probes. Mol Imaging 2009;8:7290.2009.00011. [DOI: 10.2310/7290.2009.00011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
167 De Marchi A, Brach del Prever EM, Linari A, Pozza S, Verga L, Albertini U, Forni M, Gino GC, Comandone A, Brach del Prever AM, Piana R, Faletti C. Accuracy of core-needle biopsy after contrast-enhanced ultrasound in soft-tissue tumours. Eur Radiol 2010;20:2740-8. [PMID: 20582701 DOI: 10.1007/s00330-010-1847-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
168 Cai H, Fissekis J, Conti PS. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling. Dalton Trans 2009;:5395-400. [PMID: 19565091 DOI: 10.1039/b902210d] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
169 Yang Y, Zhang Y, Hong H, Liu G, Leigh BR, Cai W. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis. Eur J Nucl Med Mol Imaging. 2011;38:2066-2076. [PMID: 21814852 DOI: 10.1007/s00259-011-1886-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
170 Melemenidis S, Jefferson A, Ruparelia N, Akhtar AM, Xie J, Allen D, Hamilton A, Larkin JR, Perez-Balderas F, Smart SC, Muschel RJ, Chen X, Sibson NR, Choudhury RP. Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates. Theranostics 2015;5:515-29. [PMID: 25767618 DOI: 10.7150/thno.10319] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
171 Ilovich O, Billauer H, Dotan S, Mishani E. Labeled 3-aryl-4-indolylmaleimide derivatives and their potential as angiogenic PET biomarkers. Bioorg Med Chem 2010;18:612-20. [PMID: 20031417 DOI: 10.1016/j.bmc.2009.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
172 Feng W, Han C, Li F. Upconversion-nanophosphor-based functional nanocomposites. Adv Mater 2013;25:5287-303. [PMID: 23982981 DOI: 10.1002/adma.201301946] [Cited by in Crossref: 174] [Cited by in F6Publishing: 141] [Article Influence: 19.3] [Reference Citation Analysis]
173 Ziaco B, Diana D, Capasso D, Palumbo R, Celentano V, Di Stasi R, Fattorusso R, D’andrea LD. C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties. Biochemical and Biophysical Research Communications 2012;424:290-4. [DOI: 10.1016/j.bbrc.2012.06.109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
174 Nayak TR, Krasteva LK, Cai W. Multimodality imaging of RNA interference. Curr Med Chem 2013;20:3664-75. [PMID: 23745567 DOI: 10.2174/0929867311320290012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
175 Zafarnia S, Bzyl-Ibach J, Spivak I, Li Y, Koletnik S, Doleschel D, Rix A, Pochon S, Tardy I, Koyadan S, van Zandvoort M, Palmowski M, Kiessling F, Lederle W. Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response. Neoplasia 2017;19:896-907. [PMID: 28938160 DOI: 10.1016/j.neo.2017.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
176 Penet MF, Mikhaylova M, Li C, Krishnamachary B, Glunde K, Pathak AP, Bhujwalla ZM. Applications of molecular MRI and optical imaging in cancer. Future Med Chem 2010;2:975-88. [PMID: 20634999 DOI: 10.4155/fmc.10.25] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
177 Kessinger CW, Togao O, Khemtong C, Huang G, Takahashi M, Gao J. Investigation of In Vivo Targeting Kinetics of α(v)β(3)-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI. Theranostics 2011;1:263-73. [PMID: 21562632 DOI: 10.7150/thno/v01p0263] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
178 Taichi M, Nomura S, Nakase I, Imamaki R, Kizuka Y, Ota F, Dohmae N, Kitazume S, Taniguchi N, Tanaka K. In Situ Ligation of High- and Low-Affinity Ligands to Cell Surface Receptors Enables Highly Selective Recognition. Adv Sci (Weinh) 2017;4:1700147. [PMID: 29201607 DOI: 10.1002/advs.201700147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
179 Bernsen MR, Kooiman K, Segbers M, van Leeuwen FW, de Jong M. Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging 2015;42:579-96. [PMID: 25673052 DOI: 10.1007/s00259-014-2980-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
180 Niu G, Chen X. Lymphatic imaging: focus on imaging probes. Theranostics 2015;5:686-97. [PMID: 25897334 DOI: 10.7150/thno.11862] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
181 Iagaru A, Mosci C, Shen B, Chin FT, Mittra E, Telli ML, Gambhir SS. 18 F-FPPRGD2 PET/CT: Pilot Phase Evaluation of Breast Cancer Patients. Radiology 2014;273:549-59. [DOI: 10.1148/radiol.14140028] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
182 Eisenblätter M, Höltke C, Persigehl T, Bremer C. Optical techniques for the molecular imaging of angiogenesis. Eur J Nucl Med Mol Imaging 2010;37 Suppl 1:S127-37. [PMID: 20632173 DOI: 10.1007/s00259-010-1514-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
183 Shi S, Chen F, Ehlerding EB, Cai W. Surface engineering of graphene-based nanomaterials for biomedical applications. Bioconjug Chem 2014;25:1609-19. [PMID: 25117569 DOI: 10.1021/bc500332c] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
184 Crawley N, Thompson M, Romaschin A. Theranostics in the Growing Field of Personalized Medicine: An Analytical Chemistry Perspective. Anal Chem 2014;86:130-60. [DOI: 10.1021/ac4038812] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
185 Berry CR, Garg P. Perspectives in molecular imaging through translational research, human medicine, and veterinary medicine. Semin Nucl Med 2014;44:66-75. [PMID: 24314047 DOI: 10.1053/j.semnuclmed.2013.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
186 Chen K, Li Z, Wang H, Cai W, Chen X. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur J Nucl Med Mol Imaging 2008;35:2235-44. [DOI: 10.1007/s00259-008-0860-8] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 10.4] [Reference Citation Analysis]
187 Wang H, Zheng L, Feng Y, Xie X, Zhao J, Wang X, Zhang G. A comparison of 3D-CTA and 4D-CE-MRA for the dynamic monitoring of angiogenesis in a rabbit VX2 tumor. European Journal of Radiology 2012;81:104-10. [DOI: 10.1016/j.ejrad.2010.03.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
188 Li Z, Yin S, Cheng L, Yang K, Li Y, Liu Z. Magnetic Targeting Enhanced Theranostic Strategy Based on Multimodal Imaging for Selective Ablation of Cancer. Adv Funct Mater 2014;24:2312-21. [DOI: 10.1002/adfm.201303345] [Cited by in Crossref: 84] [Cited by in F6Publishing: 66] [Article Influence: 9.3] [Reference Citation Analysis]
189 Kenry, Duan Y, Liu B. Recent Advances of Optical Imaging in the Second Near-Infrared Window. Adv Mater 2018;30:1802394. [DOI: 10.1002/adma.201802394] [Cited by in Crossref: 230] [Cited by in F6Publishing: 184] [Article Influence: 57.5] [Reference Citation Analysis]
190 Cyran CC, Sennino B, Fu Y, Rogut V, Shames DM, Chaopathomkul B, Wendland MF, McDonald DM, Brasch RC, Raatschen HJ. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF). Eur J Radiol 2012;81:891-6. [PMID: 21889860 DOI: 10.1016/j.ejrad.2011.07.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
191 Zhang Y, Nayak TR, Hong H, Cai W. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 2012;4:3833-42. [PMID: 22653227 DOI: 10.1039/c2nr31040f] [Cited by in Crossref: 380] [Cited by in F6Publishing: 320] [Article Influence: 38.0] [Reference Citation Analysis]
192 Liu J, Bu W, Zhang S, Chen F, Xing H, Pan L, Zhou L, Peng W, Shi J. Controlled synthesis of uniform and monodisperse upconversion core/mesoporous silica shell nanocomposites for bimodal imaging. Chemistry 2012;18:2335-41. [PMID: 22252972 DOI: 10.1002/chem.201102599] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 11.0] [Reference Citation Analysis]
193 Schottelius M, Laufer B, Kessler H, Wester HJ. Ligands for mapping alphavbeta3-integrin expression in vivo. Acc Chem Res 2009;42:969-80. [PMID: 19489579 DOI: 10.1021/ar800243b] [Cited by in Crossref: 234] [Cited by in F6Publishing: 230] [Article Influence: 18.0] [Reference Citation Analysis]
194 Jo J, Lin X, Nakahara T, Aoki I, Saga T, Tabata Y. Preparation of Polymer-Based Magnetic Resonance Imaging Contrast Agent to Visualize Therapeutic Angiogenesis. Tissue Engineering Part A 2013;19:30-9. [DOI: 10.1089/ten.tea.2012.0131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
195 Liu S. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem 2009;20:2199-213. [PMID: 19719118 DOI: 10.1021/bc900167c] [Cited by in Crossref: 235] [Cited by in F6Publishing: 231] [Article Influence: 19.6] [Reference Citation Analysis]
196 Shi S, Yang K, Hong H, Valdovinos HF, Nayak TR, Zhang Y, Theuer CP, Barnhart TE, Liu Z, Cai W. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials 2013;34:3002-9. [PMID: 23374706 DOI: 10.1016/j.biomaterials.2013.01.047] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 12.7] [Reference Citation Analysis]
197 Saga T, Koizumi M, Furukawa T, Yoshikawa K, Fujibayashi Y. Molecular imaging of cancer: evaluating characters of individual cancer by PET/SPECT imaging. Cancer Sci. 2009;100:375-381. [PMID: 19154408 DOI: 10.1111/j.1349-7006.2008.01060.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
198 Srivatsan A, Chen X. Recent Advances in Nanoparticle-Based Nuclear Imaging of Cancers. Emerging Applications of Molecular Imaging to Oncology. Elsevier; 2014. pp. 83-129. [DOI: 10.1016/b978-0-12-411638-2.00003-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
199 Zhen Z, Tang W, Chen H, Lin X, Todd T, Wang G, Cowger T, Chen X, Xie J. RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS Nano 2013;7:4830-7. [PMID: 23718215 DOI: 10.1021/nn305791q] [Cited by in Crossref: 247] [Cited by in F6Publishing: 232] [Article Influence: 27.4] [Reference Citation Analysis]
200 Pu F, Qiao J, Xue S, Yang H, Patel A, Wei L, Hekmatyar K, Salarian M, Grossniklaus HE, Liu ZR, Yang JJ. GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI. Sci Rep 2015;5:16214. [PMID: 26577829 DOI: 10.1038/srep16214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
201 Chen F, Cai W. Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials. Small 2014;10:1887-93. [PMID: 24591109 DOI: 10.1002/smll.201303627] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
202 Cowger T, Xie J. Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging. Methods Mol Biol 2013;1025:225-35. [PMID: 23918341 DOI: 10.1007/978-1-62703-462-3_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
203 Hedhli J, Kim M, Knox HJ, Cole JA, Huynh T, Schuelke M, Dobrucki IT, Kalinowski L, Chan J, Sinusas AJ, Insana MF, Dobrucki LW. Imaging the Landmarks of Vascular Recovery. Theranostics 2020;10:1733-45. [PMID: 32042333 DOI: 10.7150/thno.36022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Wang H, Zheng LF, Feng Y, Xie XQ, Yang XM, Zhang GX. CTA combined with CT perfusion for assessing the efficacy of anti-angiogenic therapy in rabbit VX2 tumors. Acad Radiol 2012;19:358-65. [PMID: 22310524 DOI: 10.1016/j.acra.2011.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
205 Deng Q, Hu B, Cao S, Song HN, Chen JL, Zhou Q. Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium. Int J Mol Med 2015;36:335-44. [PMID: 26035181 DOI: 10.3892/ijmm.2015.2226] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
206 Lécuyer T, Teston E, Ramirez-Garcia G, Maldiney T, Viana B, Seguin J, Mignet N, Scherman D, Richard C. Chemically engineered persistent luminescence nanoprobes for bioimaging. Theranostics 2016;6:2488-524. [PMID: 27877248 DOI: 10.7150/thno.16589] [Cited by in Crossref: 114] [Cited by in F6Publishing: 80] [Article Influence: 19.0] [Reference Citation Analysis]
207 Ma X, Liu Q. Preparation of poly(N-isopropylacrylamide)-block-(acrylic acid)-encapsulated proteinaceous microbubbles for delivery of doxorubicin. Colloids Surf B Biointerfaces 2017;154:115-22. [PMID: 28334688 DOI: 10.1016/j.colsurfb.2017.03.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
208 Histed SN, Lindenberg ML, Mena E, Turkbey B, Choyke PL, Kurdziel KA. Review of functional/anatomical imaging in oncology. Nucl Med Commun. 2012;33:349-361. [PMID: 22314804 DOI: 10.1097/mnm.0b013e32834ec8a5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 43] [Article Influence: 11.2] [Reference Citation Analysis]
209 Shi S, Chen F, Goel S, Graves SA, Luo H, Theuer CP, Engle JW, Cai W. In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem. Nanomicro Lett 2018;10:65. [PMID: 30393713 DOI: 10.1007/s40820-018-0216-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
210 Goel S, Chen F, Ehlerding EB, Cai W. Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small 2014;10:3825-30. [PMID: 24978934 DOI: 10.1002/smll.201401048] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
211 Lei Y, Zeng L, Xie S, Fan K, Yu Y, Chen J, Zhang S, Wang Z, Zhong L. Sertraline/ICG-loaded liposome for dual-modality imaging and effective chemo-photothermal combination therapy against metastatic clear cell renal cell carcinoma. Chem Biol Drug Des 2020;95:320-31. [PMID: 31820570 DOI: 10.1111/cbdd.13652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Iagaru A, Gambhir SS. Imaging tumor angiogenesis: the road to clinical utility. AJR Am J Roentgenol. 2013;201:W183-W191. [PMID: 23883233 DOI: 10.2214/AJR.12.8568] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
213 Walter A, Paul-gilloteaux P, Plochberger B, Sefc L, Verkade P, Mannheim JG, Slezak P, Unterhuber A, Marchetti-deschmann M, Ogris M, Bühler K, Fixler D, Geyer SH, Weninger WJ, Glösmann M, Handschuh S, Wanek T. Correlated Multimodal Imaging in Life Sciences: Expanding the Biomedical Horizon. Front Phys 2020;8:47. [DOI: 10.3389/fphy.2020.00047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
214 Hong H, Sun J, Cai W. Anatomical and molecular imaging of skin cancer. Clin Cosmet Investig Dermatol 2008;1:1-17. [PMID: 21437135 DOI: 10.2147/ccid.s4249] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
215 Xie W, Deng WW, Zan M, Rao L, Yu GT, Zhu DM, Wu WT, Chen B, Ji LW, Chen L, Liu K, Guo SS, Huang HM, Zhang WF, Zhao X, Yuan Y, Dong W, Sun ZJ, Liu W. Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy. ACS Nano 2019;13:2849-57. [PMID: 30803232 DOI: 10.1021/acsnano.8b03788] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 32.7] [Reference Citation Analysis]
216 Qian C, Chen Y, Zhu S, Yu J, Zhang L, Feng P, Tang X, Hu Q, Sun W, Lu Y, Xiao X, Shen QD, Gu Z. ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging. Theranostics 2016;6:1053-64. [PMID: 27217838 DOI: 10.7150/thno.14843] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
217 Coran A, Di Maggio A, Rastrelli M, Alberioli E, Attar S, Ortolan P, Bortolanza C, Tosi A, Montesco MC, Bezzon E, Rossi CR, Stramare R. Core needle biopsy of soft tissue tumors, CEUS vs US guided: a pilot study. J Ultrasound 2015;18:335-42. [PMID: 26550072 DOI: 10.1007/s40477-015-0161-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
218 James KT, O'toole MG, Patel DN, Zhang G, Gobin AM, Keynton RS. A high yield, controllable process for producing tunable near infrared-absorbing gold nanoplates. RSC Adv 2015;5:12498-505. [DOI: 10.1039/c4ra14889d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
219 Zhang MY, Jiang HJ, Jiang H, Zhang RJ, Wang ZC. Micro-positron emission tomography imaging of angiogenesis based on 18F-RGD for assessing liver metastasis of colorectal cancer. Hepatobiliary Pancreat Dis Int 2021;20:345-51. [PMID: 33753000 DOI: 10.1016/j.hbpd.2021.03.001] [Reference Citation Analysis]
220 Gaertner FC, Kessler H, Wester HJ, Schwaiger M, Beer AJ. Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging 2012;39 Suppl 1:S126-38. [PMID: 22388629 DOI: 10.1007/s00259-011-2028-1] [Cited by in Crossref: 161] [Cited by in F6Publishing: 152] [Article Influence: 16.1] [Reference Citation Analysis]
221 Hernandez R, Valdovinos HF, Yang Y, Chakravarty R, Hong H, Barnhart TE, Cai W. (44)Sc: an attractive isotope for peptide-based PET imaging. Mol Pharm 2014;11:2954-61. [PMID: 25054618 DOI: 10.1021/mp500343j] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
222 Xia A, Chen M, Gao Y, Wu D, Feng W, Li F. Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials 2012;33:5394-405. [PMID: 22560666 DOI: 10.1016/j.biomaterials.2012.04.025] [Cited by in Crossref: 210] [Cited by in F6Publishing: 182] [Article Influence: 21.0] [Reference Citation Analysis]
223 Yankeelov TE, Gore JC. Has quantitative multimodal imaging of treatment response arrived? Clin Cancer Res 2009;15:6473-5. [PMID: 19861463 DOI: 10.1158/1078-0432.CCR-09-2257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Lee SY, Jeon SI, Jung S, Chung IJ, Ahn CH. Targeted multimodal imaging modalities. Adv Drug Deliv Rev 2014;76:60-78. [PMID: 25064554 DOI: 10.1016/j.addr.2014.07.009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 8.8] [Reference Citation Analysis]
225 Wu T, Zheng WL, Zhang SZ, Sun JH, Yuan H. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice. World J Gastroenterol 2011; 17(31): 3614-3622 [PMID: 21987608 DOI: 10.3748/wjg.v17.i31.3614] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
226 Ji S, Czerwinski A, Zhou Y, Shao G, Valenzuela F, Sowiński P, Chauhan S, Pennington M, Liu S. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging. Mol Pharm 2013;10:3304-14. [PMID: 23875883 DOI: 10.1021/mp400085d] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
227 Liu Z, Peng R. Inorganic nanomaterials for tumor angiogenesis imaging. Eur J Nucl Med Mol Imaging 2010;37:147-63. [DOI: 10.1007/s00259-010-1452-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
228 Seward GK, Bai Y, Khan NS, Dmochowski IJ. Cell-compatible, integrin-targeted cryptophane-129Xe NMR biosensors. Chem Sci 2011;2:1103-10. [PMID: 25364495 DOI: 10.1039/C1SC00041A] [Cited by in Crossref: 71] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
229 Kessinger CW, Khemtong C, Togao O, Takahashi M, Sumer BD, Gao J. In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes. Exp Biol Med (Maywood) 2010;235:957-65. [PMID: 20660096 DOI: 10.1258/ebm.2010.010096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
230 Liu S, Liu Z, Chen K, Yan Y, Watzlowik P, Wester HJ, Chin FT, Chen X. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression. Mol Imaging Biol 2010;12:530-8. [PMID: 19949981 DOI: 10.1007/s11307-009-0284-2] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 7.7] [Reference Citation Analysis]
231 Zhang Y, Hong H, Cai W. Tumor-targeted drug delivery with aptamers. Curr Med Chem 2011;18:4185-94. [PMID: 21838687 DOI: 10.2174/092986711797189547] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 7.7] [Reference Citation Analysis]
232 Chen F, Cai W, Hong H. Engineering of Mesoporous Silica Nanoparticles for In Vivo Cancer Imaging and Therapy. In: Cai W, editor. Engineering in Translational Medicine. London: Springer; 2014. pp. 611-40. [DOI: 10.1007/978-1-4471-4372-7_23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
233 Rakhimov MG, Maruk AY, Bruskin AB. Compounds for radionuclide imaging and therapy of malignant foci characterized by the increased angiogenesis. Russ Chem Bull 2016;65:363-83. [DOI: 10.1007/s11172-016-1309-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Xiao Y, Hong H, Javadi A, Engle JW, Xu W, Yang Y, Zhang Y, Barnhart TE, Cai W, Gong S. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials 2012;33:3071-82. [PMID: 22281424 DOI: 10.1016/j.biomaterials.2011.12.030] [Cited by in Crossref: 178] [Cited by in F6Publishing: 159] [Article Influence: 17.8] [Reference Citation Analysis]
235 Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B. Antivascular agents for non-small-cell lung cancer: current status and future directions. Expert Opinion on Investigational Drugs 2009;18:1667-86. [DOI: 10.1517/13543780903336050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
236 Chakraborty S, Das S, Chakravarty R, Sarma HD, Vatsa R, Shukla J, Mittal BR, Dash A. An improved kit formulation for one-pot synthesis of [99m Tc]Tc-HYNIC-E[c(RGDfK)]2 for routine clinical use in cancer imaging. J Labelled Comp Radiopharm 2019;62:823-34. [PMID: 31315149 DOI: 10.1002/jlcr.3786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
237 Chakravarty R, Hong H, Cai W. Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature. Curr Drug Targets 2015;16:592-609. [PMID: 25182469 DOI: 10.2174/1389450115666140902125657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
238 Cheng B, Bandi V, Wei MY, Pei Y, D'Souza F, Nguyen KT, Hong Y, Yuan B. High-Resolution Ultrasound-Switchable Fluorescence Imaging in Centimeter-Deep Tissue Phantoms with High Signal-To-Noise Ratio and High Sensitivity via Novel Contrast Agents. PLoS One 2016;11:e0165963. [PMID: 27829050 DOI: 10.1371/journal.pone.0165963] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
239 Hernandez R, Czerwinski A, Chakravarty R, Graves SA, Yang Y, England CG, Nickles RJ, Valenzuela F, Cai W. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃. Eur J Nucl Med Mol Imaging 2015;42:1859-68. [PMID: 26016906 DOI: 10.1007/s00259-015-3085-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
240 Hong H, Yang Y, Liu B, Cai W. Imaging of Abdominal Aortic Aneurysm: the present and the future. Curr Vasc Pharmacol 2010;8:808-19. [PMID: 20180767 DOI: 10.2174/157016110793563898] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
241 Minamimoto R, Jamali M, Barkhodari A, Mosci C, Mittra E, Shen B, Chin F, Gambhir SS, Iagaru A. Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurements. Eur J Nucl Med Mol Imaging 2015;42:1850-8. [PMID: 26062933 DOI: 10.1007/s00259-015-3096-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
242 Shi S, Chen F, Cai W. Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging. Nanomedicine (Lond) 2013;8:2027-39. [PMID: 24279491 DOI: 10.2217/nnm.13.177] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
243 Guo N, Zhang F, Zhang X, Guo J, Lang L, Kiesewetter DO, Niu G, Li Q, Chen X. Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET. Mol Imaging Biol 2015;17:865-73. [PMID: 25896816 DOI: 10.1007/s11307-015-0854-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
244 Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH. Mouse models in neurological disorders: applications of non-invasive imaging. Biochim Biophys Acta 2010;1802:819-39. [PMID: 20471478 DOI: 10.1016/j.bbadis.2010.04.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
245 Laganà A, Venditti I, Fratoddi I, Capriotti AL, Caruso G, Battocchio C, Polzonetti G, Acconcia F, Marino M, Russo MV. Nanostructured functional co-polymers bioconjugate integrin inhibitors. Journal of Colloid and Interface Science 2011;361:465-71. [DOI: 10.1016/j.jcis.2011.05.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
246 Kandukuri J, Yu S, Cheng B, Bandi V, D'Souza F, Nguyen KT, Hong Y, Yuan B. A Dual-Modality System for Both Multi-Color Ultrasound-Switchable Fluorescence and Ultrasound Imaging. Int J Mol Sci 2017;18:E323. [PMID: 28165390 DOI: 10.3390/ijms18020323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
247 Masłowska K, Halik PK, Tymecka D, Misicka A, Gniazdowska E. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy. Cancers (Basel) 2021;13:1072. [PMID: 33802353 DOI: 10.3390/cancers13051072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
248 Chen ZY, Wang YX, Lin Y, Zhang JS, Yang F, Zhou QL, Liao YY. Advance of molecular imaging technology and targeted imaging agent in imaging and therapy. Biomed Res Int 2014;2014:819324. [PMID: 24689058 DOI: 10.1155/2014/819324] [Cited by in Crossref: 29] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
249 . Current world literature. Trauma and rehabilitation. Curr Opin Neurol 2008;21:762-4. [PMID: 18989123 DOI: 10.1097/WCO.0b013e32831cbb85] [Reference Citation Analysis]
250 Chakraborty S, Shi J, Kim YS, Zhou Y, Jia B, Wang F, Liu S. Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent. Bioconjug Chem 2010;21:969-78. [PMID: 20387808 DOI: 10.1021/bc900555q] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
251 Qian C, Yu J, Chen Y, Hu Q, Xiao X, Sun W, Wang C, Feng P, Shen QD, Gu Z. Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy. Adv Mater 2016;28:3313-20. [PMID: 26948067 DOI: 10.1002/adma.201505869] [Cited by in Crossref: 307] [Cited by in F6Publishing: 298] [Article Influence: 51.2] [Reference Citation Analysis]
252 Morrison AR, Sinusas AJ. Advances in radionuclide molecular imaging in myocardial biology. J Nucl Cardiol 2010;17:116-34. [PMID: 20012514 DOI: 10.1007/s12350-009-9167-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
253 Hong H, Chen F, Zhang Y, Cai W. New radiotracers for imaging of vascular targets in angiogenesis-related diseases. Adv Drug Deliv Rev 2014;76:2-20. [PMID: 25086372 DOI: 10.1016/j.addr.2014.07.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
254 Zhao H, Zhao H, Jiao Y, Zhu Y, Liu C, Li F, Wang Y, Gu Z, Yang D. Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imaging. Biomaterials 2020;256:120220. [DOI: 10.1016/j.biomaterials.2020.120220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
255 Wang H, Yang H, Xu ZP, Liu X, Roberts MS, Liang X. Anionic Long-Circulating Quantum Dots for Long-Term Intravital Vascular Imaging. Pharmaceutics 2018;10:E244. [PMID: 30463341 DOI: 10.3390/pharmaceutics10040244] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
256 Paprottka PM, Zengel P, Cyran CC, Paprottka KJ, Ingrisch M, Nikolaou K, Reiser MF, Clevert DA. Evaluation of multimodality imaging using image fusion with MRI and CEUS in an experimental animal model. Clin Hemorheol Microcirc 2015;61:143-50. [PMID: 26519228 DOI: 10.3233/CH-151986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Liu G, Swierczewska M, Niu G, Zhang X, Chen X. Molecular imaging of cell-based cancer immunotherapy. Mol Biosyst 2011;7:993-1003. [PMID: 21308113 DOI: 10.1039/c0mb00198h] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
258 Zhou Y, Chakraborty S, Liu S. Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics 2011;1:58-82. [PMID: 21547153 DOI: 10.7150/thno/v01p0058] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 7.5] [Reference Citation Analysis]
259 Mirshojaei SF, Ahmadi A, Morales-avila E, Ortiz-reynoso M, Reyes-perez H. Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer. Journal of Drug Targeting 2016;24:91-101. [DOI: 10.3109/1061186x.2015.1048516] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
260 Wittenborn TR, Larsen EK, Nielsen T, Rydtoft LM, Hansen L, Nygaard JV, Vorup-Jensen T, Kjems J, Horsman MR, Nielsen NC. Accumulation of nano-sized particles in a murine model of angiogenesis. Biochem Biophys Res Commun 2014;443:470-6. [PMID: 24321551 DOI: 10.1016/j.bbrc.2013.11.127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
261 Maity A, Bernhard EJ. Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy. Cancer Res 2010;70:2141-5. [PMID: 20179191 DOI: 10.1158/0008-5472.CAN-09-3615] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
262 Jadvar H. Molecular Imaging of Prostate Cancer: A Concise Synopsis. Mol Imaging 2009;8:7290.2009.00010. [DOI: 10.2310/7290.2009.00010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
263 Liu L, Song Y, Gao S, Ji T, Zhang H, Ji B, Chen B, Jia B, Wang F, Xu Z, Ma Q. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions. Mol Imaging 2014;13. [PMID: 24825112 DOI: 10.2310/7290.2014.00010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
264 Yanev P, Dijkhuizen RM. In vivo imaging of neurovascular remodeling after stroke. Stroke 2012;43:3436-41. [PMID: 23019247 DOI: 10.1161/STROKEAHA.111.642686] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
265 Jansen JF, Koutcher JA, Shukla-Dave A. Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma. Angiogenesis. 2010;13:149-160. [PMID: 20383743 DOI: 10.1007/s10456-010-9167-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
266 Silindir M, Erdoğan S, Özer AY, Maia S. Liposomes and their applications in molecular imaging. Journal of Drug Targeting 2012;20:401-15. [DOI: 10.3109/1061186x.2012.685477] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
267 Plebani M. Biochemical and imaging biomarkers: the search for the Holy Grail. Clinical Chemistry and Laboratory Medicine 2010;48. [DOI: 10.1515/cclm.2010.199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
268 Chen N, Li S, Battig MR, Wang Y. Programmable imaging amplification via nanoparticle-initiated DNA polymerization. Small 2013;9:3944-9. [PMID: 23813897 DOI: 10.1002/smll.201300806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
269 Moyer BR, Barrett JA. Biomarkers and imaging: physics and chemistry for noninvasive analyses. Bioanalysis 2009;1:321-56. [DOI: 10.4155/bio.09.30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
270 Peng Y, Yang D, Lu W, Hu X, Hong H, Cai T. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance. Acta Biomater 2017;61:193-203. [PMID: 28801268 DOI: 10.1016/j.actbio.2017.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
271 Xing Y, Zhao J, Conti PS, Chen K. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics 2014;4:290-306. [PMID: 24505237 DOI: 10.7150/thno.7341] [Cited by in Crossref: 145] [Cited by in F6Publishing: 123] [Article Influence: 18.1] [Reference Citation Analysis]
272 Shi J, Wang L, Kim YS, Zhai S, Liu Z, Chen X, Liu S. Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers. J Med Chem 2008;51:7980-90. [PMID: 19049428 DOI: 10.1021/jm801134k] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 6.6] [Reference Citation Analysis]
273 Wu Y, Gao D, Zhang P, Li C, Wan Q, Chen C, Gong P, Gao G, Sheng Z, Cai L. Iron oxide nanoparticles protected by NIR-active multidentate-polymers as multifunctional nanoprobes for NIRF/PA/MR trimodal imaging. Nanoscale 2016;8:775-9. [PMID: 26658484 DOI: 10.1039/c5nr06660c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
274 Zhang R, Xiong C, Huang M, Zhou M, Huang Q, Wen X, Liang D, Li C. Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. Biomaterials 2011;32:5872-9. [PMID: 21612822 DOI: 10.1016/j.biomaterials.2011.04.070] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
275 Zhang Y, Hong H, Niu G, Valdovinos HF, Orbay H, Nayak TR, Chen X, Barnhart TE, Cai W. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. Mol Pharm 2012;9:3586-94. [PMID: 23137334 DOI: 10.1021/mp3005269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
276 Xing H, Zheng X, Ren Q, Bu W, Ge W, Xiao Q, Zhang S, Wei C, Qu H, Wang Z, Hua Y, Zhou L, Peng W, Zhao K, Shi J. Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements. Sci Rep 2013;3:1751. [PMID: 23624542 DOI: 10.1038/srep01751] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 8.8] [Reference Citation Analysis]
277 Patel S, Bhirde AA, Rusling JF, Chen X, Gutkind JS, Patel V. Nano delivers big: designing molecular missiles for cancer therapeutics. Pharmaceutics 2011;3:34-52. [PMID: 21949900 DOI: 10.3390/pharmaceutics3010034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
278 Kim MH, Kim CG, Kim S, Kim D. Synthesis and evaluation of Tc-99m and fluorescence-labeled elastin-derived peptide, VAPG for multimodal tumor imaging in murine tumor model. J Label Compd Radiopharm 2017;60:649-58. [DOI: 10.1002/jlcr.3572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
279 Gao L, Liu H, Sun X, Gao D, Zhang C, Jia B, Zhu Z, Wang F, Liu Z. Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy. J Nucl Med 2016;57:321-6. [PMID: 26383149 DOI: 10.2967/jnumed.115.158881] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
280 McDevitt MR, Scheinberg DA. Fibrillous carbon nanotube: an unexpected journey. Crit Rev Oncog 2014;19:261-8. [PMID: 25271434 DOI: 10.1615/critrevoncog.2014011442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
281 Jiang L, Miao Z, Kimura RH, Liu H, Cochran JR, Culter CS, Bao A, Li P, Cheng Z. Preliminary evaluation of 177Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy. Eur J Nucl Med Mol Imaging 2011;38:613-22. [DOI: 10.1007/s00259-010-1684-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
282 Laroui H, Rakhya P, Xiao B, Viennois E, Merlin D. Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders. Dig Liver Dis 2013;45:995-1002. [PMID: 23660079 DOI: 10.1016/j.dld.2013.03.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
283 Shirshahi V, Soltani M. Solid silica nanoparticles: applications in molecular imaging. Contrast Media Mol Imaging 2015;10:1-17. [PMID: 24996058 DOI: 10.1002/cmmi.1611] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
284 Zhou Y, Kim Y, Chakraborty S, Shi J, Gao H, Liu S. 99m Tc-Labeled Cyclic RGD Peptides for Noninvasive Monitoring of Tumor Integrin α v β 3 Expression. Mol Imaging 2011;10:7290.2011.00006. [DOI: 10.2310/7290.2011.00006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
285 Chen F, Bu W, Cai W, Shi J. Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research. Curr Mol Med 2013;13:1613-32. [PMID: 24206131 DOI: 10.2174/1566524013666131111122133] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
286 Lin X, Xie J, Niu G, Zhang F, Gao H, Yang M, Quan Q, Aronova MA, Zhang G, Lee S. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 2011;11:814-819. [PMID: 21210706 DOI: 10.1021/nl104141g] [Cited by in Crossref: 183] [Cited by in F6Publishing: 165] [Article Influence: 16.6] [Reference Citation Analysis]
287 Papathanassiou D, Bruna-muraille C, Liehn J, Nguyen TD, Curé H. Positron Emission Tomography in oncology: Present and future of PET and PET/CT. Critical Reviews in Oncology/Hematology 2009;72:239-54. [DOI: 10.1016/j.critrevonc.2008.10.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
288 O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 2017;14:169-86. [PMID: 27725679 DOI: 10.1038/nrclinonc.2016.162] [Cited by in Crossref: 405] [Cited by in F6Publishing: 371] [Article Influence: 67.5] [Reference Citation Analysis]
289 Gong H, Dong Z, Liu Y, Yin S, Cheng L, Xi W, Xiang J, Liu K, Li Y, Liu Z. Engineering of Multifunctional Nano-Micelles for Combined Photothermal and Photodynamic Therapy Under the Guidance of Multimodal Imaging. Adv Funct Mater 2014;24:6492-502. [DOI: 10.1002/adfm.201401451] [Cited by in Crossref: 209] [Cited by in F6Publishing: 171] [Article Influence: 26.1] [Reference Citation Analysis]
290 Zhou C, Hao G, Thomas P, Liu J, Yu M, Sun S, Öz OK, Sun X, Zheng J. Near-Infrared Emitting Radioactive Gold Nanoparticles with Molecular Pharmacokinetics. Angew Chem 2012;124:10265-9. [DOI: 10.1002/ange.201203031] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
291 Tan H, Yu L, Gao F, Liao W, Wang W, Zeng W. Surface modification: how nanoparticles assemble to molecular imaging probes. J Nanopart Res 2013;15. [DOI: 10.1007/s11051-013-2100-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
292 Golestani R, Sadeghi MM. Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management. J Nucl Cardiol 2014;21:251-67; quiz 268-70. [PMID: 24381115 DOI: 10.1007/s12350-013-9845-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
293 Hong H, Shi J, Yang Y, Zhang Y, Engle JW, Nickles RJ, Wang X, Cai W. Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Lett 2011;11:3744-50. [PMID: 21823599 DOI: 10.1021/nl201782m] [Cited by in Crossref: 150] [Cited by in F6Publishing: 119] [Article Influence: 13.6] [Reference Citation Analysis]
294 Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. Int J Nanomedicine 2012;7:4391-408. [PMID: 22927757 DOI: 10.2147/IJN.S33838] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
295 Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 2008;1:17-32. [PMID: 24198458 DOI: 10.2147/nsa.s3788] [Cited by in Crossref: 481] [Cited by in F6Publishing: 116] [Article Influence: 34.4] [Reference Citation Analysis]
296 Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6:715-728. [PMID: 21718180 DOI: 10.2217/nnm.11.19] [Cited by in Crossref: 1313] [Cited by in F6Publishing: 1196] [Article Influence: 119.4] [Reference Citation Analysis]
297 Yang G, Sun H, Kong Y, Hou G, Han J. Diversity of RGD radiotracers in monitoring antiangiogenesis of flavopiridol and paclitaxel in ovarian cancer xenograft-bearing mice. Nuclear Medicine and Biology 2014;41:856-62. [DOI: 10.1016/j.nucmedbio.2014.08.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
298 Silindir M, Özer AY, Erdoğan S. The use and importance of liposomes in positron emission tomography. Drug Deliv 2012;19:68-80. [PMID: 22211758 DOI: 10.3109/10717544.2011.635721] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
299 Vojtech JM, Cano-Mejia J, Dumont MF, Sze RW, Fernandes R. Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applications. J Vis Exp 2015;:e52621. [PMID: 25993028 DOI: 10.3791/52621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
300 Yang Y, Niu Y, Hong H, Wu H, Zhang Y, Engle JW, Barnhart TE, Cai J, Cai W. Radiolabeled γ-AApeptides: a new class of tracers for positron emission tomography. Chem Commun (Camb) 2012;48:7850-2. [PMID: 22785080 DOI: 10.1039/c2cc33620k] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
301 Cyran CC, Schwarz B, Paprottka PM, Sourbron S, von Einem JC, Dietrich O, Hinkel R, Clevert DA, Bruns CJ, Reiser MF, Nikolaou K, Wintersperger BJ. In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media. Cancer Imaging 2013;13:557-66. [PMID: 24380871 DOI: 10.1102/1470-7330.2013.0049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
302 Atukorale PU, Covarrubias G, Bauer L, Karathanasis E. Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. Adv Drug Deliv Rev 2017;113:141-56. [PMID: 27639317 DOI: 10.1016/j.addr.2016.09.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
303 Shi J, Kim YS, Chakraborty S, Jia B, Wang F, Liu S. 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics. Bioconjug Chem 2009;20:1559-68. [PMID: 19603780 DOI: 10.1021/bc9001739] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
304 Cyran CC, Paprottka PM, Schwarz B, Sourbron S, Ingrisch M, von Einem J, Pietsch H, Dietrich O, Hinkel R, Bruns CJ, Reiser MF, Wintersperger BJ, Nikolaou K. Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study. AJR Am J Roentgenol 2012;198:384-91. [PMID: 22268182 DOI: 10.2214/AJR.11.6951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
305 Hamada K, Tomita Y, Qiu Y, Tomoeda M, Ueda T, Tamai N, Hashimoto N, Yoshikawa H, Aozasa K, Hatazawa J. 18F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors. Skeletal Radiol 2009;38:261-6. [DOI: 10.1007/s00256-008-0612-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
306 Chen K, Wang X, Lin WY, Shen CK, Yap LP, Hughes LD, Conti PS. Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes. ACS Med Chem Lett 2012;3:1019-23. [PMID: 24900423 DOI: 10.1021/ml300236m] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
307 Ma J, Huang P, He M, Pan L, Zhou Z, Feng L, Gao G, Cui D. Folic acid-conjugated LaF3:Yb,Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography. J Phys Chem B 2012;116:14062-70. [PMID: 23134318 DOI: 10.1021/jp309059u] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 8.4] [Reference Citation Analysis]
308 Thi Kim Dung D, Fukushima S, Furukawa T, Niioka H, Sannomiya T, Kobayashi K, Yukawa H, Baba Y, Hashimoto M, Miyake J. Multispectral Emissions of Lanthanide-Doped Gadolinium Oxide Nanophosphors for Cathodoluminescence and Near-Infrared Upconversion/Downconversion Imaging. Nanomaterials (Basel) 2016;6:E163. [PMID: 28335291 DOI: 10.3390/nano6090163] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
309 Ehling J, Lammers T, Kiessling F. Non-invasive imaging for studying anti-angiogenic therapy effects. Thromb Haemost 2013;109:375-90. [PMID: 23407722 DOI: 10.1160/TH12-10-0721] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
310 Minamimoto R, Karam A, Jamali M, Barkhodari A, Gambhir SS, Dorigo O, Iagaru A. Pilot prospective evaluation of 18F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer. Eur J Nucl Med Mol Imaging 2016;43:1047-55. [DOI: 10.1007/s00259-015-3263-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
311 Zhang Y, Hong H, Cai W. Imaging with Raman spectroscopy. Curr Pharm Biotechnol 2010;11:654-61. [PMID: 20497112 DOI: 10.2174/138920110792246483] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
312 Asghar W, Shafiee H, Chen P, Tasoglu S, Guven S, Gurkan UA, Demirci U. In Vitro Three-Dimensional Cancer Culture Models. In: Bae YH, Mrsny RJ, Park K, editors. Cancer Targeted Drug Delivery. New York: Springer; 2013. pp. 635-65. [DOI: 10.1007/978-1-4614-7876-8_24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
313 Hahnenkamp A, Schäfers M, Bremer C, Höltke C. Design and synthesis of small-molecule fluorescent photoprobes targeted to aminopeptdase N (APN/CD13) for optical imaging of angiogenesis. Bioconjug Chem 2013;24:1027-38. [PMID: 23642127 DOI: 10.1021/bc400074w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
314 Hyoun Kim M, Kim SG, Guhn Kim C, Kim DW. A novel Tc-99m and fluorescence labeled peptide as a multimodal imaging agent for targeting angiogenesis in a murine hindlimb ischemia model. Appl Radiat Isot 2017;121:22-7. [PMID: 28013153 DOI: 10.1016/j.apradiso.2016.12.026] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
315 Wei W, Ehlerding EB, Lan X, Luo Q, Cai W. PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging 2018;45:132-50. [PMID: 29085965 DOI: 10.1007/s00259-017-3839-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
316 Eliceiri KW, Contag CH. Integrated studies of biology: multiplexed imaging assays from molecules to man and back. Current Opinion in Biotechnology 2009;20:1-3. [DOI: 10.1016/j.copbio.2009.04.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
317 Jiang L, Kimura RH, Ma X, Tu Y, Miao Z, Shen B, Chin FT, Shi H, Gambhir SS, Cheng Z. A radiofluorinated divalent cystine knot peptide for tumor PET imaging. Mol Pharm 2014;11:3885-92. [PMID: 24717098 DOI: 10.1021/mp500018s] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
318 Pei Y, Wei MY, Cheng B, Liu Y, Xie Z, Nguyen K, Yuan B. High resolution imaging beyond the acoustic diffraction limit in deep tissue via ultrasound-switchable NIR fluorescence. Sci Rep. 2014;4:4690. [PMID: 24732947 DOI: 10.1038/srep04690] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
319 Xu CT, Zhan Q, Liu H, Somesfalean G, Qian J, He S, Andersson-engels S. Upconverting nanoparticles for pre-clinical diffuse optical imaging, microscopy and sensing: Current trends and future challenges: Upconverting nanoparticles. Laser & Photonics Reviews 2013;7:663-97. [DOI: 10.1002/lpor.201200052] [Cited by in Crossref: 115] [Cited by in F6Publishing: 76] [Article Influence: 12.8] [Reference Citation Analysis]
320 Bolley J, Lalatonne Y, Haddad O, Letourneur D, Soussan M, Pérard-viret J, Motte L. Optimized multimodal nanoplatforms for targeting αvβ3 integrins. Nanoscale 2013;5:11478. [DOI: 10.1039/c3nr03763k] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
321 Hong H, Zhang Y, Engle JW, Nayak TR, Theuer CP, Nickles RJ, Barnhart TE, Cai W. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials 2012;33:4147-56. [PMID: 22386918 DOI: 10.1016/j.biomaterials.2012.02.031] [Cited by in Crossref: 149] [Cited by in F6Publishing: 130] [Article Influence: 14.9] [Reference Citation Analysis]
322 Zhu Y, Hong H, Xu ZP, Li Z, Cai W. Quantum dot-based nanoprobes for in vivo targeted imaging. Curr Mol Med 2013;13:1549-67. [PMID: 24206136 DOI: 10.2174/1566524013666131111121733] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
323 Punitha N, Ramesh P, Geetha D. Spectral, morphological and antibacterial studies of β-cyclodextrin stabilized silver – Chitosan nanocomposites. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2015;136:1710-7. [DOI: 10.1016/j.saa.2014.10.071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
324 Hong H, Zhang Y, Orbay H, Valdovinos HF, Nayak TR, Bean J, Theuer CP, Barnhart TE, Cai W. Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment. Mol Pharm 2013;10:709-16. [PMID: 23316869 DOI: 10.1021/mp300507r] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
325 James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 2012;92:897-965. [PMID: 22535898 DOI: 10.1152/physrev.00049.2010] [Cited by in Crossref: 584] [Cited by in F6Publishing: 508] [Article Influence: 58.4] [Reference Citation Analysis]
326 Zhang L, Zhao D. Liposomal encapsulation enhances in vivo near infrared imaging of exposed phosphatidylserine in a mouse glioma model. Molecules 2013;18:14613-28. [PMID: 24287994 DOI: 10.3390/molecules181214613] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
327 Hwang J, Ramella-Roman JC, Nordstrom R. Introduction: feature issue on phantoms for the performance evaluation and validation of optical medical imaging devices. Biomed Opt Express 2012;3:1399-403. [PMID: 22741084 DOI: 10.1364/BOE.3.001399] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
328 Leung SJ, Rice PS, Barton JK. In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis. Lasers Surg Med. 2015;47:40-49. [PMID: 25487746 DOI: 10.1002/lsm.22309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
329 Miao T, Oldinski RA, Liu G, Chen X. Nanotheranostics-Based Imaging for Cancer Treatment Monitoring. In: Rai P, Morris SA, editors. Nanotheranostics for Cancer Applications. Cham: Springer International Publishing; 2019. pp. 395-428. [DOI: 10.1007/978-3-030-01775-0_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
330 Hao D, Sun L, Hu X, Hao X. 99mTc-LHRH in tumor receptor imaging. Oncol Lett 2017;14:569-78. [PMID: 28693207 DOI: 10.3892/ol.2017.6246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
331 Jia B, Liu Z, Zhu Z, Shi J, Jin X, Zhao H, Li F, Liu S, Wang F. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD 2 in non-human primates. Mol Imaging Biol 2011;13:730-6. [PMID: 20694579 DOI: 10.1007/s11307-010-0385-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
332 Olafsen T, Wu AM. Antibody vectors for imaging. Semin Nucl Med. 2010;40:167-181. [PMID: 20350626 DOI: 10.1053/j.semnuclmed.2009.12.005] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
333 Lee S, Barbe MF, Scalia R, Goldfinger LE. Three-dimensional reconstruction of neovasculature in solid tumors and basement membrane matrix using ex vivo X-ray microcomputed tomography. Microcirculation 2014;21:159-70. [PMID: 25279426 DOI: 10.1111/micc.12102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
334 Swierczewska M, Lee S, Chen X. Inorganic Nanoparticles for Multimodal Molecular Imaging. Mol Imaging 2011;10:7290.2011.00001. [DOI: 10.2310/7290.2011.00001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
335 Eschbach RS, Fendler WP, Kazmierczak PM, Hacker M, Rominger A, Carlsen J, Hirner-Eppeneder H, Schuster J, Moser M, Havla L, Schneider MJ, Ingrisch M, Spaeth L, Reiser MF, Nikolaou K, Cyran CC. Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation. PLoS One 2015;10:e0115543. [PMID: 25668193 DOI: 10.1371/journal.pone.0115543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
336 Hong H, Yang Y, Zhang Y, Cai W. Non-invasive imaging of human embryonic stem cells. Curr Pharm Biotechnol 2010;11:685-92. [PMID: 20497109 DOI: 10.2174/138920110792246500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
337 Yun JY, Hyun BH, Nam SY, Yun YW, Lee HJ, Lee BJ. The effect of near-infrared fluorescence conjugation on the anti-cancer potential of cetuximab. Lab Anim Res 2018;34:30-6. [PMID: 29628974 DOI: 10.5625/lar.2018.34.1.30] [Reference Citation Analysis]
338 Cerniglia GJ, Pore N, Tsai JH, Schultz S, Mick R, Choe R, Xing X, Durduran T, Yodh AG, Evans SM, Koch CJ, Hahn SM, Quon H, Sehgal CM, Lee WM, Maity A. Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One 2009;4:e6539. [PMID: 19657384 DOI: 10.1371/journal.pone.0006539] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 6.9] [Reference Citation Analysis]
339 Deshayes E, Dunet V, Rüegg C, Prior J. Imagerie de la néoangiogenèse en médecine nucléaire. Médecine Nucléaire 2012;36:619-26. [DOI: 10.1016/j.mednuc.2012.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
340 Seyyednia E, Oroojalian F, Baradaran B, Mojarrad JS, Mokhtarzadeh A, Valizadeh H. Nanoparticles modified with vasculature-homing peptides for targeted cancer therapy and angiogenesis imaging. J Control Release 2021;338:367-93. [PMID: 34461174 DOI: 10.1016/j.jconrel.2021.08.044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Toktas ZO, Akgun E, Ozkan A, Bozkurt SU, Bekiroglu N, Seker A, Konya D, Kilic T. Relationship of Angiogenic Potential With Clinical Features in Cranial Meningiomas: A Corneal Angiogenesis Study: . Neurosurgery 2010;67:1724-32. [DOI: 10.1227/neu.0b013e3181f9f310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
342 Tijink BM, Perk LR, Budde M, Stigter-van Walsum M, Visser GW, Kloet RW, Dinkelborg LM, Leemans CR, Neri D, van Dongen GA. (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy. Eur J Nucl Med Mol Imaging 2009;36:1235-44. [PMID: 19259661 DOI: 10.1007/s00259-009-1096-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]
343 Kim N, Choi J, Yi J, Choi S, Park S, Chang Y, Seo JB. An engineering view on megatrends in radiology: digitization to quantitative tools of medicine. Korean J Radiol 2013;14:139-53. [PMID: 23482650 DOI: 10.3348/kjr.2013.14.2.139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
344 Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010;62:1064-79. [PMID: 20691229 DOI: 10.1016/j.addr.2010.07.009] [Cited by in Crossref: 924] [Cited by in F6Publishing: 817] [Article Influence: 77.0] [Reference Citation Analysis]
345 Zhang N, Cai X, Gao W, Wang R, Xu C, Yao Y, Hao L, Sheng D, Chen H, Wang Z, Zheng Y. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy. Theranostics 2016;6:404-17. [PMID: 26909114 DOI: 10.7150/thno.13478] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 8.3] [Reference Citation Analysis]
346 Kim MH, Kim SG, Kim DW. Tc-99m and Fluorescence-Labeled Anti-Flt1 Peptide as a Multimodal Tumor Imaging Agent Targeting Vascular Endothelial Growth Factor-Receptor 1. Nucl Med Mol Imaging 2018;52:359-67. [PMID: 30344784 DOI: 10.1007/s13139-018-0535-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
347 Müller J, Wunder A, Licha K. Optical imaging. Recent Results Cancer Res 2013;187:221-46. [PMID: 23179883 DOI: 10.1007/978-3-642-10853-2_7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
348 Yang Y, Hong H, Zhang Y, Cai W. Molecular Imaging of Proteases in Cancer. Cancer Growth Metastasis 2009;2:13-27. [PMID: 20234801 DOI: 10.4137/cgm.s2814] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
349 Cai W, Guzman R, Hsu AR, Wang H, Chen K, Sun G, Gera A, Choi R, Bliss T, He L, Li Z, Maag AD, Hori N, Zhao H, Moseley M, Steinberg GK, Chen X. Positron Emission Tomography Imaging of Poststroke Angiogenesis. Stroke 2009;40:270-7. [DOI: 10.1161/strokeaha.108.517474] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
350 Sheth RA, Mahmood U. Optical molecular imaging and its emerging role in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2010;299:G807-G820. [PMID: 20595618 DOI: 10.1152/ajpgi.00195.2010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
351 Wen X, Wang Y, Zhang F, Zhang X, Lu L, Shuai X, Shen J. In vivo monitoring of neural stem cells after transplantation in acute cerebral infarction with dual-modal MR imaging and optical imaging. Biomaterials 2014;35:4627-35. [DOI: 10.1016/j.biomaterials.2014.02.042] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
352 Forte E, Fiorenza D, Torino E, Costagliola di Polidoro A, Cavaliere C, Netti PA, Salvatore M, Aiello M. Radiolabeled PET/MRI Nanoparticles for Tumor Imaging. J Clin Med 2019;9:E89. [PMID: 31905769 DOI: 10.3390/jcm9010089] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
353 Wang GD, Chen H, Tang W, Lee D, Xie J. Gd and Eu Co-Doped Nanoscale Metal-Organic Framework as a T1-T2 Dual-Modal Contrast Agent for Magnetic Resonance Imaging. Tomography 2016;2:179-87. [PMID: 30042963 DOI: 10.18383/j.tom.2016.00226] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
354 Zhu L, Guo N, Li Q, Ma Y, Jacboson O, Lee S, Choi HS, Mansfield JR, Niu G, Chen X. Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe. Theranostics 2012;2:746-56. [PMID: 22916074 DOI: 10.7150/thno.4762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
355 Zhang Y, Hong H, Orbay H, Valdovinos HF, Nayak TR, Theuer CP, Barnhart TE, Cai W. PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment. Eur J Nucl Med Mol Imaging 2013;40:759-67. [PMID: 23344138 DOI: 10.1007/s00259-012-2334-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
356 Wang H, Wang K, Tian B, Revia R, Mu Q, Jeon M, Chang FC, Zhang M. Preloading of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging, NIR-Responsive Drug Release, and Synergistic Therapy. Small 2016;12:6388-97. [PMID: 27671114 DOI: 10.1002/smll.201602263] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
357 He T, Smith N, Saunders D, Doblas S, Watanabe Y, Hoyle J, Silasi-Mansat R, Lupu F, Lerner M, Brackett DJ, Towner RA. Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas. J Cell Mol Med 2011;15:837-49. [PMID: 20497492 DOI: 10.1111/j.1582-4934.2010.01091.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]